Institute For Clinical Research is categorized under Medical Labs in Washington, DC and active since 1996.
Institute For Clinical Research was established in 1996, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Medical Labs business, which does work in the B2C market, and is classified as a Medical Labs, under code number 621511 by the NAICS.
If you are seeking more information, feel free to contact Gamal El-Gamassy at the company’s single location by writing to 901 23rd St Nw # 5312n, Washington, District of Columbia DC 20037 or by phoning (202) 994-0001. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Institute For Clinical Research |
| Contact Person: | Gamal El-Gamassy |
| Address: | 901 23rd St Nw # 5312n, Washington, District of Columbia 20037 |
| Phone Number: | (202) 994-0001 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 1996 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Medical Labs |
| SIC Code: | 8071 |
| NAICS Code: | 621511 |
| Share This Business: |
Institute For Clinical Research was started in 1996 to provide professional Medical Labs under the SIC code 8071 and NAICS code 621511. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Gamal El-Gamassy for inquiries that concern Institute For Clinical Research by calling the company number (202) 994-0001, as your correspondence is most welcome. Additionally, the physical location of the single location of Institute For Clinical Research can be found at the coordinates 38.901142,-77.049934 as well as the street address 901 23rd St Nw # 5312n in Washington, District of Columbia 20037.
For its online presence, you may visit Institute For Clinical Research’s website at and engage with its social media outlets through on Twitter and on Facebook.